Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease
- 23 June 2016
- journal article
- review article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 30 (3) , 295-337
Abstract
Sporadic Alzheimer’s disease (AD) is a devastating neurodegenerative disorder. It is essential to unravel its etiology and pathogenesis. This should enable us to study the presymptomatic stages of the disease and to analyze and reverse the antemortem behavioral, memory, and cognitive dysfunction. Prima facie, an ongoing chronic vulnerability involving neural insult may lead normal elderly to mild cognitive impairment (MCI) and then to AD. Development of effective preventive and therapeutic strategies to thwart the disease pathology obviously requires a thorough delineation of underlying disruptive neuropathological processes. Our sensory capacity for touch, smell, taste, hearing, and vision declines with advancing age. Declines in different sensory attributes are considered here to be the primary “first-tier pathologies.” Olfactory loss is among the first clinical signs of neurodegenerative diseases including AD and Parkinson’s disease (PD). Sensory dysfunction in the aged promotes pathological disturbances in the locus coeruleus, basal forebrain, entorhinal cortex, hippocampus, and several key areas of neocortex and brainstem. Hence, sensory dysfunction is the pivotal factor that may upregulate cognitive and memory dysfunction. The age-related constellation of comorbid pathological factors may include apolipoprotein E (APOE) genotype, obesity, diabetes, hypertension, alcohol abuse, head trauma, and obstructive sleep apnea. The concepts and trajectories delineated here are the dynamic pillars of the current hypothesis presented—it postulates that the sensory decline, in conjunction with the above pathologies, is crucial in triggering neurodegeneration and promoting cognitive/memory dysfunction in aging and AD. The application of this thesis can be important in formulating new multifactorial preventive and treatment strategies (suggested here) in order to attenuate cognitive and memory decline and ameliorate pathological dysfunction in aging, MCI, and AD.Keywords
This publication has 664 references indexed in Scilit:
- Cerebral Blood Flow Modulation by Basal Forebrain or Whisker Stimulation Can Occur Independently of Large Cytosolic Ca2+ Signaling in AstrocytesPLOS ONE, 2013
- Sporadic Alzheimer’s Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer’s Disease GenesMolecular Neurobiology, 2013
- The benefits of cholinergic enhancement during perceptual learning are long-lastingFrontiers in Computational Neuroscience, 2013
- Prevalence of Hearing Aid Use Among Older Adults in the United StatesArchives of internal medicine (1960), 2012
- Dendritic Degeneration, Neurovascular Defects, and Inflammation Precede Neuronal Loss in a Mouse Model for Tau-Mediated NeurodegenerationThe American Journal of Pathology, 2011
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label studyMovement Disorders, 2008
- Central Auditory Dysfunction in Older Persons With Memory Impairment or Alzheimer DementiaJAMA Otolaryngology–Head & Neck Surgery, 2008
- The Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineJAMA, 2004
- Brainstem afferents to the basal forebrain in the ratNeuroscience, 1988